| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
51,268,000 |
| Market
Cap: |
2.10(B) |
| Last
Volume: |
1,397,232 |
Avg
Vol: |
593,465 |
| 52
Week Range: |
$27.67 - $67.63 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : 6.2 |
| Insider 6 Months : 27.4 |
| Insider 3/6 Months : 34 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile STAAR Surgical designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. Co.'s products are implantable Collamer lenses (ICLs) used in refractive surgery and intraocular lenses (IOLs) used in cataract surgery. ICLs, consisting of Co.'s ICL family of products, including the Toric implantable Collamer lenses and EVO+ Visian ICL, are intraocular lenses used to correct refractive conditions such as myopia, hyperopia, astigmatism, and presbyopia. IOLs are prosthetic intraocular lenses used to restore vision that has been affected by cataracts, and include Co.'s lines of silicone IOLs and the Preloaded Injector.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
1,750 |
982,422 |
1,992,448 |
2,183,523 |
| Total Buy Value |
$66,693 |
$30,859,566 |
$69,506,378 |
$78,567,953 |
| Total People Bought |
1 |
4 |
5 |
5 |
| Total Buy Transactions |
1 |
24 |
52 |
58 |
| Total Shares Sold |
0 |
0 |
0 |
157,830 |
| Total Sell Value |
$0 |
$0 |
$0 |
$10,505,424 |
| Total People Sold |
0 |
0 |
0 |
3 |
| Total Sell Transactions |
0 |
0 |
0 |
6 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Michna Magda |
Chief Clinical, Regulatory, |
• – – |
2023-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,047 |
14,047 |
|
- |
|
| Francese James E |
Sr. VP, Comm. Ops., NA, APAC |
• – – |
2023-03-20 |
4 |
D |
$62.07 |
$49,470 |
D/D |
(797) |
42,660 |
|
- |
|
| Barnes Scott D |
Chief Medical Officer |
• – – |
2023-03-20 |
4 |
D |
$62.07 |
$56,546 |
D/D |
(911) |
41,502 |
|
- |
|
| Holliday Keith |
Chief Technology Officer |
• – – |
2023-03-20 |
4 |
D |
$62.07 |
$56,297 |
D/D |
(907) |
28,157 |
|
- |
|
| Gesten Samuel J |
Chief Legal Officer |
• – – |
2023-03-20 |
4 |
D |
$62.07 |
$55,366 |
D/D |
(892) |
43,665 |
|
- |
|
| Holliday Keith |
Chief Technology Officer |
• – – |
2023-03-17 |
4 |
S |
$61.97 |
$51,001 |
D/D |
(823) |
27,633 |
|
9% |
|
| Francese James E |
Sr. VP, Comm. Ops., NA, APAC |
• – – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,388 |
42,374 |
|
- |
|
| Francese James E |
Sr. VP, Comm. Ops., NA, APAC |
• – – |
2023-03-10 |
4 |
D |
$56.63 |
$14,158 |
D/D |
(250) |
33,986 |
|
- |
|
| Holliday Keith |
Chief Technology Officer |
• – – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,192 |
28,456 |
|
- |
|
| Holliday Keith |
Chief Technology Officer |
• – – |
2023-03-10 |
4 |
D |
$56.63 |
$16,083 |
D/D |
(284) |
18,264 |
|
- |
|
| Gesten Samuel J |
Chief Legal Officer |
• – – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,531 |
43,219 |
|
- |
|
| Gesten Samuel J |
Chief Legal Officer |
• – – |
2023-03-10 |
4 |
D |
$56.63 |
$15,856 |
D/D |
(280) |
33,688 |
|
- |
|
| Williams Patrick F. |
Chief Financial Officer |
• – – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,184 |
45,676 |
|
- |
|
| Williams Patrick F. |
Chief Financial Officer |
• – – |
2023-03-10 |
4 |
D |
$56.63 |
$16,366 |
D/D |
(289) |
33,492 |
|
- |
|
| Barnes Scott D |
Chief Medical Officer |
• – – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,555 |
40,810 |
|
- |
|
| Barnes Scott D |
Chief Medical Officer |
• – – |
2023-03-10 |
4 |
D |
$56.63 |
$16,140 |
D/D |
(285) |
30,255 |
|
- |
|
| Studholme Robert |
Senior VP, Operations |
• – – |
2023-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,859 |
31,980 |
|
- |
|
| Francese James E |
Sr. VP, Comm. Ops., NA, APAC |
• – – |
2023-03-07 |
4 |
OE |
$58.13 |
$62,955 |
D/D |
1,083 |
35,319 |
|
- |
|
| Francese James E |
Sr. VP, Comm. Ops., NA, APAC |
• – – |
2023-03-07 |
4 |
D |
$58.13 |
$39,063 |
D/D |
(672) |
34,236 |
|
- |
|
| Barnes Scott D |
Chief Medical Officer |
• – – |
2023-03-07 |
4 |
OE |
$58.13 |
$93,182 |
D/D |
1,603 |
32,143 |
|
- |
|
| Barnes Scott D |
Chief Medical Officer |
• – – |
2023-03-07 |
4 |
D |
$58.13 |
$45,167 |
D/D |
(777) |
30,540 |
|
- |
|
| Holliday Keith |
Chief Technology Officer |
• – – |
2023-03-07 |
4 |
OE |
$58.13 |
$83,184 |
D/D |
1,431 |
19,979 |
|
- |
|
| Holliday Keith |
Chief Technology Officer |
• – – |
2023-03-07 |
4 |
D |
$58.13 |
$51,678 |
D/D |
(889) |
18,548 |
|
- |
|
| Studholme Robert |
Senior VP, Operations |
• – – |
2023-03-07 |
4 |
OE |
$58.13 |
$99,344 |
D/D |
1,709 |
23,121 |
|
- |
|
| Gesten Samuel J |
Chief Legal Officer |
• – – |
2023-03-07 |
4 |
OE |
$58.13 |
$77,778 |
D/D |
1,338 |
35,306 |
|
- |
|
127 Records found
|
|
Page 4 of 6 |
|
|
5.63 (12.07%) 
